The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study
Open accessAbstract
Background: Proteins pathogenic in Alzheimer's disease (AD) were extracted from neurally derived blood exosomes and quantified to develop biomarkers for the staging of sporadic AD. Methods: Blood exosomes obtained at one time‐point from patients with AD (n = 57) or frontotemporal dementia (FTD) (n = 16), and at two time‐points from others (n = 24) when cognitively normal and 1 to 10 years later when diagnosed with AD were enriched for neural sources by immunoabsorption. AD‐pathogenic exosomal proteins were extracted and quantified by enzyme‐linked immunosorbent assays. Results: Mean exosomal levels of total tau, P‐T181‐tau, P‐S396‐tau, and amyloid β 1–42 (Aβ1–42) for AD and levels of P‐T181‐tau and Aβ1–42 for FTD were significantly higher than for case‐controls. Step‐wise discriminant modeling incorporated P‐T181‐tau, P‐S396‐tau, and Aβ1–42 in AD, but only P‐T181‐tau in FTD. Classification of 96.4% of AD patients and 87.5% of FTD patients was correct. In 24 AD patients, exosomal levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 were significantly higher than for controls both 1 to 10 years before and when diagnosed with AD. Conclusions: Levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 in extracts of neurally derived blood exosomes predict the development of AD up to 10 years before clinical onset.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Altered EV profiles are detectable at prodromal stages such as MCI, supporting their value as early biomarkers. 26 , 27”
From Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's disease (2026) · cites this paper as [26]
In the citing paper
“Exosomes isolated from the brain, cerebrospinal fluid (CSF), and plasma of AD patients and/or AD animal models contain pathologic Aβ and tau [73, 75–77].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [77]
In the citing paper
“Interestingly, increased levels of exosome-associated tau have been found by some groups in the CSF and blood of individuals with AD and FTDs [55, 117].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationResearch criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Melnick, V. L., & Dubler, N. N. (1985) · Contemporary Issues in Biomedicine, Ethics, and Society · doi:10.1007/978-1-4612-5174-3 · Cited by 1,986
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,060
Self-citationSaman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985
Cited by
Sorted by citations
Items 101–200 of 961
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment
Hosseini, N. F., Sheykhhasan, M., Asl, S. S., & Najafi, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02324-x · Cited by 155
Biomarkers for Alzheimer’s Disease Early Diagnosis
Ausó, E., Gómez‐Vicente, V., & Esquiva, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030114 · Cited by 159
Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics
Wang, W., Luo, J., & Wang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800484 · Cited by 151
Pathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 152
MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior
Allen, L., & Dwivedi, Y. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0597-8 · Cited by 152
The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
Blennow, K., & Zetterberg, H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170773 · Cited by 154
MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy
Dong, R., Liu, Y., Yang, Y., Wang, H., Xu, Y., & Zhang, Z. (2019) · BioMed Research International · doi:10.1155/2019/6458237 · Cited by 149
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Uddin, M. S., & Lim, L. W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101622 · Cited by 154
Recent Progress in Detection and Profiling of Cancer Cell‐Derived Exosomes
Xiong, H., Huang, Z., Yang, Z., Lin, Q., Yang, B., Fang, X., Liu, B., Chen, H., & Kong, J. (2021) · Small · doi:10.1002/smll.202007971 · Cited by 144
Huo, L., Du, X., Li, X., Liu, S., & Xu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.738442 · Cited by 149
A review on comparative studies addressing exosome isolation methods from body fluids
Martins, T. S., Vaz, M., & Henriques, A. G. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04174-5 · Cited by 146
The aged rhesus macaque manifests Braak stage III/IV Alzheimer's‐like pathology
Paspalas, C. D., Carlyle, B. C., Leslie, S., Preuss, T. M., Crimins, J. L., Huttner, A. J., van Dyck, C. H., Rosene, D. L., Nairn, A. C., & Arnsten, A. F. T. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.11.005 · Cited by 140
Dozio, V., & Sanchez, J. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1302705 · Cited by 137
The emerging role of exosomes in Alzheimer’s disease
Zhang, T., Ma, S., Lv, J., Wang, X., Afewerky, H. K., Li, H. R., & Lu, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101321 · Cited by 141
Emerging roles of extracellular vesicles in neurodegenerative disorders
You, Y., & Ikezu, T. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104512 · Cited by 138
Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Clayton, K. A., Enoo, A. A. V., & Ikezu, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00680 · Cited by 137
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan, Y., Chen, Z., & Zhang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03493-6 · Cited by 134
Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease
Giau, V. V., & An, S. S. A. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.005 · Cited by 133
Exosomes in Parkinson’s Disease
Wu, X., Zheng, T., & Zhang, B. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0092-z · Cited by 136
Agliardi, C., Guerini, F. R., Zanzottera, M., Bianchi, A., Nemni, R., & Clerici, M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1501-x · Cited by 127
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Hamlett, E. D., Goetzl, E. J., Ledreux, A., Vasilevko, V., Boger, H. A., LaRosa, A., Clark, D., Carroll, S. L., Carmona‐Iragui, M., Fortea, J., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.012 · Cited by 129
Self-citationEitan, E., Hutchison, E. R., Marosi, K., Comotto, J., Mustapic, M., Nigam, S. M., Suire, C., Maharana, C., Jicha, G. A., Liu, D., et al. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.19 · Cited by 129
Self-citationBlood-based biomarkers for Alzheimer’s disease—An update
Zetterberg, H. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.10.025 · Cited by 128
Mullins, R. J., Mustapić, M., Goetzl, E. J., & Kapogiannis, D. (2017) · Human Brain Mapping · doi:10.1002/hbm.23494 · Cited by 131
Self-citationExosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease
Jiang, L., Dong, H., Cao, H., Ji, X., Luan, S., & Liu, J. (2019) · Medical Science Monitor · doi:10.12659/msm.914027 · Cited by 130
Ohmichi, T., Mitsuhashi, M., Tatebe, H., Kasai, T., El‐Agnaf, O. M. A., & Tokuda, T. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.11.021 · Cited by 129
Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
Lee, S., Mankhong, S., & Kang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071728 · Cited by 129
Telocytes and Their Extracellular Vesicles—Evidence and Hypotheses
Crețoiu, D., Xu, J., Xiao, J., & Creţoiu, S. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081322 · Cited by 124
Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV
Sun, B., Dalvi, P., Abadjian, L. R., Tang, N., & Pulliam, L. (2017) · AIDS · doi:10.1097/qad.0000000000001595 · Cited by 123
The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
Perea, J. R., Llorens-Martín, M., Ávila, J., & Bolós, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00172 · Cited by 129
Picciolini, S., Gualerzi, A., Vanna, R., Sguassero, A., Gramatica, F., Bedoni, M., Masserini, M., & Morasso, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00941 · Cited by 122
Cohn, W., Melnik, M., Huang, C., Teter, B., Chandra, S., Zhu, C., McIntire, L. B., John, V., Gylys, K. H., & Bilousova, T. V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.766082 · Cited by 123
Propagation of Tau via Extracellular Vesicles
Pérez, M., Avila, J., & Hernández, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00698 · Cited by 118
Huang, Y., Cheng, L., Turchinovich, A. A., Mahairaki, V., Troncoso, J. C., Pletniková, O., Haughey, N. J., Vella, L. J., Hill, A. F., Zheng, L., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1785746 · Cited by 118
Insulin resistance in Alzheimer's disease
Diehl, T. C., Mullins, R. J., & Kapogiannis, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.005 · Cited by 124
Self-citationSARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Peluso, M. J., Deeks, S. G., Mustapić, M., Kapogiannis, D., Henrich, T. J., Lu, S., Goldberg, S. A., Hoh, R., Chen, J. Y., Martinez, E. O., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26350 · Cited by 116
Self-citationPhysical characterization and profiling of airway epithelial derived exosomes using light scattering
Kesımer, M., & Gupta, R. (2015) · Methods · doi:10.1016/j.ymeth.2015.03.013 · Cited by 116
Exosomes as Carriers of Alzheimer's Amyloid-ß
Yuyama, K., & Igarashi, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00229 · Cited by 119
Serpente, M., Fenoglio, C., D’Anca, M., Arcaro, M., Sorrentino, F., Visconte, C., Arighi, A., Fumagalli, G. G., Porretti, L., Cattaneo, A., et al. (2020) · Cells · doi:10.3390/cells9061443 · Cited by 116
Nasca, C., Dobbin, J., Bigio, B., Watson, K. T., de Angelis, P., Kautz, M. M., Cochran, A., Mathé, A. A., Kocsis, J. H., Lee, F. S., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0804-7 · Cited by 117
Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR
Gallart‐Palau, X., Serra, A., & Sze, S. K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0108-1 · Cited by 112
Winston, C. N., Romero, H. K., Ellisman, M., Nauss, S., Julovich, D. A., Conger, T., Hall, J. R., Campana, W., O’Bryant, S. E., Nievergelt, C. M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01005 · Cited by 105
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
Dong, X., Nao, J., Shi, J., & Zheng, D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00332 · Cited by 110
Extracellular Vesicles in neural cell interaction and CNS homeostasis
Schnatz, A., Müller, C., Brahmer, A., & Krämer‐Albers, E. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00035 · Cited by 112
Gaetani, L., Paoletti, F. P., Bellomo, G., Mancini, A., Simoni, S., Filippo, M. D., & Parnetti, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.011 · Cited by 110
Kumar, A., Su, Y., Sharma, M., Singh, S., Kim, S., Peavey, J. J., Suerken, C. K., Lockhart, S. N., Whitlow, C. T., Craft, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13055 · Cited by 113
Zou, Z., Han, L., Xu, G., Hu, Y., Zhang, W., & Tian, K. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417422 · Cited by 115
Insulin resistance and exendin-4 treatment for multiple system atrophy
Bassil, F., Canron, M., Vital, A., Bézard, E., Li, Y., Greig, N. H., Gulyani, S., Kapogiannis, D., Fernagut, P., & Meissner, W. G. (2017) · Brain · doi:10.1093/brain/awx044 · Cited by 108
Self-citationExtracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
DeLeo, A. M., & Ikezu, T. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9768-z · Cited by 109
Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
Španić, E., Horvat, L. L., Hof, P. R., & Šimić, G. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00271 · Cited by 112
Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yü, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 103
Further understanding the connection between Alzheimer's disease and Down syndrome
Snyder, H. M., Bain, L. J., Brickman, A. M., Carrillo, M. C., Esbensen, A. J., Espinosa, J. M., Fernandez, F., Fortea, J., Hartley, S. L., Head, E., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12112 · Cited by 105
Wang, W., Li, M., Chen, Z., Xu, L., Chang, M., Wang, K., Deng, C., Gu, Y., Zhou, S., Shen, Y., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114954 · Cited by 110
Li, D., HUANG, S. H., Zhu, J., Hu, T., Han, Z., Zhang, S., Zhao, J. T., Chen, F., & Lei, P. (2019) · Medical Science Monitor · doi:10.12659/msm.915727 · Cited by 102
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
Zhang, H., Cao, Y., Ma, L., Wei, Y., & Li, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.707268 · Cited by 109
Katsu, M., Hama, Y., Utsumi, J., Takashina, K., Yasumatsu, H., Mori, F., Wakabayashi, K., Shoji, M., & Sasaki, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.048 · Cited by 99
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Dutta, S., Hornung, S., Taha, H. B., & Bitan, G. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02557-1 · Cited by 103
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Kang, J., Korecka, M., Figurski, M., Toledo, J. B., Blennow, K., Zetterberg, H., Waligórska, T., Brylska, M., Fields, L., Shah, N., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.003 · Cited by 100
Self-citationFetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture Media
Lehrich, B. M., Liang, Y., Khosravi, P., Federoff, H. J., & Fiandaca, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113538 · Cited by 99
Self-citationDeng, F., & Miller, J. H. (2019) · Journal of Histotechnology · doi:10.1080/01478885.2019.1646984 · Cited by 102
Nogueras‐Ortiz, C. J., Eren, E., Yao, P. J., Calzada, E., Dunn, C., Volpert, O. V., Delgado‐Peraza, F., Mustapić, M., Lyashkov, A. E., Rubio, F. J., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12459 · Cited by 101
Self-citationPotential Therapies by Stem Cell‐Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
Luarte, A., Bátiz, L. F., Wyneken, Ú., & Lafourcade, C. (2016) · Stem Cells International · doi:10.1155/2016/5736059 · Cited by 100
Extracellular vesicles of the blood-brain barrier
Andras, I. E., & Toborek, M. J. (2015) · Tissue Barriers · doi:10.1080/21688370.2015.1131804 · Cited by 98
Baker, S., Polanco, J. C., & Götz, J. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160371 · Cited by 98
A novel cell‐cell communication mechanism in the nervous system: exosomes
Zhang, G., & Yang, P. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24113 · Cited by 98
Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
Nam, E., Lee, Y., Moon, C., & Chang, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145007 · Cited by 97
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 119
Guha, D., Lorenz, D. R., Misra, V., Chettimada, S., Morgello, S., & Gabuzda, D. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1617-y · Cited by 100
Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders
Roy, B., Yoshino, Y., McKibben, L. A., Prall, K., Schell, G., & Dwivedi, Y. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00464-9 · Cited by 101
Cheng, L., Vella, L. J., Barnham, K. J., McLean, C., Masters, C. L., & Hill, A. F. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1766822 · Cited by 96
Zhang, X., Takeuchi, T., Takeda, A., Mochizuki, H., & Nagai, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270634 · Cited by 100
Extracellular vesicles in neurodegenerative diseases
Croese, T., & Furlan, R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.006 · Cited by 95
Clinical trials in REM sleep behavioural disorder: challenges and opportunities
Videnović, A., Ju, Y. S., Arnulf, I., Cock, V. C. D., Högl, B., Kunz, D., Provini, F., Ratti, P., Schiess, M. C., Schenck, C. H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322875 · Cited by 97
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Blommer, J. M., Pitcher, T. L., Mustapić, M., Eren, E., Yao, P. J., Vreones, M. P., Pucha, K. A., Dalrymple‐Alford, J. C., Shoorangiz, R., Meissner, W. G., et al. (2022) · Brain · doi:10.1093/brain/awac258 · Cited by 95
Self-citationExtracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 97
Shun, H., Zhang, L., Su, Y., Liang, X., Yang, J., Luo, Q., & Luo, H. (2024) · Science Advances · doi:10.1126/sciadv.abm3088 · Cited by 98
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Human plasma platelet‐derived exosomes: effects of aspirin
Goetzl, E. J., Goetzl, L. M., Karliner, J. S., Tang, N., & Pulliam, L. (2016) · The FASEB Journal · doi:10.1096/fj.201500150r · Cited by 91
Self-citationExtracellular vesicles as signaling mediators in type 2 diabetes mellitus
Hooten, N. N., & Evans, M. K. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00536.2019 · Cited by 94
Biomarkers for Alzheimer’s Disease in Saliva: A Systematic Review
Gleerup, H. S., Hasselbalch, S. G., & Simonsen, A. H. (2019) · Disease Markers · doi:10.1155/2019/4761054 · Cited by 90
Eitan, E., Thornton‐Wells, T. A., Elgart, K., Erden, E., Gershun, E., Levine, A. A., Volpert, O. V., Azadeh, M., Smith, D. G., & Kapogiannis, D. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.13 · Cited by 97
Self-citationJacquet, A. D. R., Tancredi, J. L., Lemire, A. L., DeSantis, M. C., Li, W., & O’Shea, E. K. (2021) · eLife · doi:10.7554/elife.73062 · Cited by 91
Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
Badhwar, A., & Haqqani, A. S. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12001 · Cited by 87
Chae, M.-S., Kim, J., Jeong, D., Kim, Y. S., Roh, J. H., Lee, S., Heo, Y., Kang, J. Y., Lee, J. H., Yoon, D. S., et al. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.10.049 · Cited by 87
A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin
Younas, N., Flores, L. C. F., Hopfner, F., Höglinger, G. U., & Zerr, I. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00301-5 · Cited by 84
Current trends in blood biomarker detection and imaging for Alzheimer’s disease
Hu, S., Yang, C., & Luo, H. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114278 · Cited by 84
Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology
Yamada, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00667 · Cited by 86
Emerging Roles of Exosomes in Huntington’s Disease
Ananbeh, H., Vodička, P., & Skalníková, H. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084085 · Cited by 84
Zheng, T., Pu, J., Chen, Y., Mao, Y., Guo, Z., Pan, H., Zhang, L., Zhang, H., Sun, B., & Zhang, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00012 · Cited by 82
Circulating extracellular vesicles in the aging process: impact of aerobic exercise
Bertoldi, K., Cechinel, L. R., Schallenberger, B., Corssac, G. B., Davies, S., Külkamp‐Guerreiro, I. C., Belló‐Klein, A., Araújo, A. S. D. R., & Siqueira, I. R. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3160-4 · Cited by 82
Soliman, H. M., Ghonaim, G. A., Gharib, S. M., Chopra, H., Farag, A. K., Hassanin, M. H., Nagah, A., Emad-Eldin, M., Hashem, N. E., Yahya, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910794 · Cited by 81
Eren, E., Hunt, J. F. V., Shardell, M. D., Chawla, S., Tran, J., Gu, J., Vogt, N. M., Johnson, S. C., Bendlin, B. B., & Kapogiannis, D. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12130 · Cited by 81
Self-citationStem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M., Das, S. K., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 82
Tian, C., Stewart, T., Hong, Z., Guo, Z., Aro, P., Soltys, D., Pan, C., Peskind, E. R., Zabetian, C. P., Shaw, L. M. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12723 · Cited by 80
Cao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 82
Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Volpert, O. V., Liu, D., Goetzl, E. J., Mattson, M. P., Greig, N. H., Eitan, E., & Kapogiannis, D. (2021) · Cells · doi:10.3390/cells10050993 · Cited by 81
Self-citationEmergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust
Kumar, A., Nader, M. A., & Deep, G. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000788 · Cited by 79
Diling, C., Guo, Y., Qi, L., Xiaocui, T., Liu, Y., Xin, Y., Guoyan, H., Shuai, O., Yong, T., Wang, D., et al. (2019) · Aging · doi:10.18632/aging.102529 · Cited by 78
RetractedEmerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis
Peng, L., Wang, D., Han, Y., Huang, T., He, X., Wang, J., & Ou, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795372 · Cited by 77
Metadata
- Authors
- Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., & Goetzl, E. J.
- Affiliations
- Georgetown University Medical Center (US)
- National Institute on Aging (US)
- University of Rochester Medicine (US)
- University of California San Francisco Medical Center (US)
- University of Kentucky (US)
- Mayo Clinic (US)
- Corresponding author
- Goetzl, Edward J.
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2014-08-14
- Volume
- 11
- Issue
- 6
- Pages
- 600
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC4329112
- OpenAlex
- W1995903088
- Cited by
- 959
- References
- 31
- Citations by year
- 2026: 77 · 2025: 91 · 2024: 109 · 2023: 86 · 2022: 115 · 2021: 106 · 2020: 105 · 2019: 93 · 2018: 46 · 2017: 50 · 2016: 50 · 2015: 24 · 2014: 3
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Aging (NIA RO1AG030753)
- National Institutes of Health (UK ADC P30 AG028383)
- Genentech
- Alzheimer's Association
- Association for Frontotemporal Degeneration
- Alzheimer's Drug Discovery Foundation
- Pfizer
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- preclinical Alzheimer's disease, blood exosomes
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Peptide Fragments, Phosphorylation, Retrospective Studies, Severity of Illness Index, Time Factors, Biomarkers, Discriminant Analysis, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Exosomes, Frontotemporal Dementia, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
